000 | 01500 a2200409 4500 | ||
---|---|---|---|
005 | 20250513115039.0 | ||
264 | 0 | _c19970424 | |
008 | 199704s 0 0 eng d | ||
022 | _a0041-1345 | ||
024 | 7 |
_a10.1016/s0041-1345(96)00670-7 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWaldman, W J | |
245 | 0 | 0 |
_aCMV as an exacerbating agent in transplant vascular sclerosis: potential immune-mediated mechanisms modelled in vitro. _h[electronic resource] |
260 |
_bTransplantation proceedings _c |
||
300 |
_a1545-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aArteriosclerosis _xetiology |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aCytomegalovirus _xphysiology |
650 | 0 | 4 |
_aCytomegalovirus Infections _xcomplications |
650 | 0 | 4 |
_aEndothelium, Vascular _ximmunology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHLA-DR Antigens _xbiosynthesis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIntercellular Adhesion Molecule-1 _xbiosynthesis |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aPostoperative Complications |
650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
650 | 0 | 4 |
_aT-Lymphocytes, Cytotoxic _ximmunology |
650 | 0 | 4 |
_aTransplantation, Homologous _ximmunology |
700 | 1 | _aAdams, P W | |
700 | 1 | _aKnight, D A | |
700 | 1 | _aSedmak, D D | |
773 | 0 |
_tTransplantation proceedings _gvol. 29 _gno. 1-2 _gp. 1545-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0041-1345(96)00670-7 _zAvailable from publisher's website |
999 |
_c9104944 _d9104944 |